Shanghai Model Organisms Center Inc - Asset Resilience Ratio

Latest as of June 2026: 35.82%

Shanghai Model Organisms Center Inc (688265) has an Asset Resilience Ratio of 35.82% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shanghai Model Organisms Center Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥714.81 Million
≈ $104.60 Million USD Cash + Short-term Investments

Total Assets

CN¥2.00 Billion
≈ $292.05 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Shanghai Model Organisms Center Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 688265 current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Model Organisms Center Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Shanghai Model Organisms Center Inc carry for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥714.81 Million 35.82%
Total Liquid Assets CN¥714.81 Million 35.82%

Asset Resilience Insights

  • Very High Liquidity: Shanghai Model Organisms Center Inc maintains exceptional liquid asset reserves at 35.82% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai Model Organisms Center Inc Industry Peers by Asset Resilience Ratio

Compare Shanghai Model Organisms Center Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Abivax SA
PA:ABVX
Biotechnology 2.58%
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
Biotechnology 2.03%
Neuren Pharmaceuticals Ltd
AU:NEU
Biotechnology 90.43%
Lifecome Biochemistry Co Ltd
SHE:002868
Biotechnology 4.69%
Pulike Biological Engineering
SHG:603566
Biotechnology 17.82%
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Biotechnology 14.00%
NEWRON PHARMACEUT. EO-20
XETRA:NP5
Biotechnology 41.67%
Upstream Bio, Inc.
NASDAQ:UPB
Biotechnology 64.70%

Annual Asset Resilience Ratio for Shanghai Model Organisms Center Inc (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Shanghai Model Organisms Center Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 44.52% CN¥883.15 Million
≈ $129.23 Million
CN¥1.98 Billion
≈ $290.25 Million
+2.52pp
2024-12-31 42.00% CN¥810.36 Million
≈ $118.58 Million
CN¥1.93 Billion
≈ $282.33 Million
-4.41pp
2023-12-31 46.42% CN¥927.28 Million
≈ $135.69 Million
CN¥2.00 Billion
≈ $292.34 Million
+9.28pp
2022-12-31 37.14% CN¥762.73 Million
≈ $111.61 Million
CN¥2.05 Billion
≈ $300.52 Million
+31.53pp
2021-12-31 5.61% CN¥110.25 Million
≈ $16.13 Million
CN¥1.96 Billion
≈ $287.40 Million
-14.01pp
2020-12-31 19.62% CN¥70.06 Million
≈ $10.25 Million
CN¥357.02 Million
≈ $52.24 Million
-20.79pp
2019-12-31 40.41% CN¥88.37 Million
≈ $12.93 Million
CN¥218.70 Million
≈ $32.00 Million
+35.91pp
2015-12-31 4.50% CN¥5.00 Million
≈ $731.66K
CN¥111.16 Million
≈ $16.27 Million
--
pp = percentage points

About Shanghai Model Organisms Center Inc

SHG:688265 China Biotechnology
Market Cap
$593.24 Million
CN¥4.05 Billion CNY
Market Cap Rank
#11533 Global
#3298 in China
Share Price
CN¥52.00
Change (1 day)
+7.00%
52-Week Range
CN¥31.14 - CN¥55.00
All Time High
CN¥73.40
About

Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. It uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. The company offers toolbox of mice; disease mice, such as rare, infectious, a… Read more